Last reviewed · How we verify
Para-probiotic oral care
Para-probiotic oral care is a Small molecule drug developed by University of Pavia. It is currently in Phase 1 development.
At a glance
| Generic name | Para-probiotic oral care |
|---|---|
| Sponsor | University of Pavia |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Para-probiotic oral care CI brief — competitive landscape report
- Para-probiotic oral care updates RSS · CI watch RSS
- University of Pavia portfolio CI
Frequently asked questions about Para-probiotic oral care
What is Para-probiotic oral care?
Para-probiotic oral care is a Small molecule drug developed by University of Pavia.
Who makes Para-probiotic oral care?
Para-probiotic oral care is developed by University of Pavia (see full University of Pavia pipeline at /company/university-of-pavia).
What development phase is Para-probiotic oral care in?
Para-probiotic oral care is in Phase 1.
Related
- Manufacturer: University of Pavia — full pipeline
- Compare: Para-probiotic oral care vs similar drugs
- Pricing: Para-probiotic oral care cost, discount & access